Immunotherapy and Radiation Therapy in Renal Cell Carcinoma.

CONCLUSION: Combining immunotherapy and radiotherapy has a strong rationale and pre-clinical studies support their association because it can overcome the immunosuppression of the tumor microenvironment and increase the anti-tumor immune response. Other: More clinical evidences, deriving from on-clinical trials, are needed to prove the efficacy and safety of these treatments combined.
PMID: 32160846 [PubMed - as supplied by publisher]

Source: Current Drug Targets - March 10, 2020 Category: Drugs & Pharmacology Authors: Mollica V, Santoni M, Di Nunno V, Cimadamore A, Cheng L, Lopez-Beltran A, Battelli N, Montironi R, Massari F Tags: Curr Drug Targets Source Type: research